← Back to Search

'On the Move' Exercise Program for Improving Mobility in Older Adults

N/A
Recruiting
Led By Jennifer S Brach, PhD, PT
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
60 years of age or older
Can ambulate household distances independently
Timeline
Screening 3 weeks
Treatment Varies
Follow Up throughout the 12 week intervention
Awards & highlights

Study Summary

This trial will test whether a physical activity intervention called 'On the Move' can improve mobility in 502 older adults, as well as evaluate how well the intervention is followed and what factors affect this.

Who is the study for?
This trial is for older adults, aged 60 and above, who can walk on their own within the house and are regulars at senior community centers. They should be able to join group exercises but cannot have unstable illnesses or plans to move away soon. Those with impaired cognition that affects understanding of consent are not eligible.Check my eligibility
What is being tested?
The 'On the Move' (OTM) group exercise program is being tested for its ability to improve mobility in older adults. The study involves 502 participants across 44 senior centers and will also assess how well the program is delivered and factors affecting it.See study design
What are the potential side effects?
Since this trial involves a physical exercise program designed for older adults, potential side effects may include muscle soreness, fatigue, or minor injuries related to physical activity. However, these risks are generally low as the program is tailored for seniors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 60 years old or older.
Select...
I can walk around my house on my own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Gait speed
Secondary outcome measures
Participant Satisfaction
Patient-Reported Outcomes Measurement Information System (PROMIS) mobility
Other outcome measures
Adaptations
Adherence - Content
Adherence - Dose of exposure classes offered
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: On the Move - DelayedExperimental Treatment1 Intervention
Individuals in this arm will be placed on a wait-list for 12 weeks and will receive no intervention during this time. At the end of the 12 weeks they will receive the On the Move group exercise program. This is a wait-list control group.
Group II: On the MoveExperimental Treatment1 Intervention
On the Move group exercise program to improve walking. Delivered twice per week for 12 weeks.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,342,444 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,423 Total Patients Enrolled
Jennifer S Brach, PhD, PTPrincipal InvestigatorUniversity of Pittsburgh
1 Previous Clinical Trials
353 Total Patients Enrolled

Media Library

On the Move group exercise Clinical Trial Eligibility Overview. Trial Name: NCT05126355 — N/A
Limited Mobility Clinical Trial 2023: On the Move group exercise Highlights & Side Effects. Trial Name: NCT05126355 — N/A
On the Move group exercise 2023 Treatment Timeline for Medical Study. Trial Name: NCT05126355 — N/A
Limited Mobility Research Study Groups: On the Move, On the Move - Delayed

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this experiment?

"Affirmative. Data located on clinicaltrials.gov indicates that this medical investigation, which was originally posted on June 23rd 2022, is actively recruiting patients. To complete the trial, 502 participants need to be recruited from a single site."

Answered by AI

What is the current enrollment total for this medical trial?

"Affirmative, according to clinicaltrials.gov this research endeavor is still recruiting volunteers. It was initially posted on June 23rd 2022 and updated most recently on July 6th 2022; the trial requires 502 patients from a single site."

Answered by AI
~211 spots leftby Aug 2025